Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

Newly identified HIV broadly neutralizing antibody is hard to escape

Feb. 11, 2020

HVTN702 HIV vaccine study stopped early due to non-efficacy

Feb. 4, 2020

Reservoir dogs don't hunt

Feb. 4, 2020

Researchers achieve the reversal of HIV and SIV latency in vivo

Jan. 27, 2020

DFH Therapeutics and HHS describe betulinic acid derivatives for HIV infection

Jan. 22, 2020

ViiV Healthcare UK patents HIV integrase inhibitors

Jan. 17, 2020

ViiV Healtcare's Dovato receives approval in Japan for HIV infection

Jan. 15, 2020

MSD KK receives approval for Pifeltro for treating HIV-1 infection

Jan. 14, 2020

Drexel University synthesizes new HIV capsid assembly inhibitors

Jan. 10, 2020

ViiV Healthcare UK describes HIV integrase inhibitors

Jan. 9, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
Ontrack Therapeutics divulges compounds for neurodegenerative diseases
BioWorld Science
Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
Reunion Neuroscience reports new 5-HT2A partial agonists and/or 5-HT2B antagonists
BioWorld Science
Reunion Neuroscience Inc. has identified new 5-HT2A receptor partial agonists and/or 5-HT2B receptor antagonists potentially useful for the treatment of...